新确科技(01063.HK)折让13%配股 净筹5,620万元
新确科技(01063.HK)公布,根据特别授权配售5.8亿股新股,占扩大後股本的38.85%。配售价为每股0.1元,较上一个交易日收市价折让13%。
公司预计,配售所得款项净额为5,620万元,其中约1,800万元将用作开发虚拟资产交易平台的网络应用开发,1,100万元将用作购置设备及相关安装及技术支持服务费,810万元将用於云基础架构及专业网络管理服务费,840万元将用作操作及技术人员以及外部顾问的员工成本及顾问费,240万元将用作数字及数据证券服务费,其余830万元将用作营运虚拟资产交易平台的营运资金,包括但不限於购买数字资产存货及购买保险。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.